Our Evidence
Cardihab's clinical trials and real world evidence consistently reinforce the benefits of our model of care in improving access to and completion of cardiac rehabilitation, clinical outcomes for patients, and providing positive experiences for clinicians.
Published Results
Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial.
World-first randomised controlled trial (RCT) of smartphone-delivered cardiac rehabilitation improved cardiac rehabilitation uptake, adherence and completion
The RCT demonstrated that the model of care underpinning the Cardihab product improves patient uptake (+29%), adherence (+38%) and completion (+70%).
Cardihab showed slight weight reduction (89±20–88±21 kg) and also demonstrated significant improvements in emotional state (anxiety and psychological distress) and improved health related quality of life.
Supporting Publications:
- Varnfield M, Karunanithi M, Lee CK, et al. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial. Heart. 2014;100(22):1770-1779. doi:10.1136/heartjnl-2014-305783
- Geach T. Rehabilitation: Smartphone-based cardiac rehabilitation - a first RCT. Nat Rev Cardiol. 2014;11(9):498. doi:10.1038/nrcardio.2014.103
The Impact of a Mobile App on Participation in Cardiac Rehabilitation and Understanding Barriers to Success: Comparative Cohort Study
Clinical study finds that offering Cardihab to people that decline cardiac rehabilitation, significantly increases participation.
A clinical study of patients with cardiovascular disease by Queensland Cardiovascular Group.
Study found that offering Cardihab to people that declined cardiac rehabilitation, substantially improved participation rates in cardiac rehabilitation from 21% to 63%.
This study also observed a low rate of hospital readmission compared to conventional models.
Published in JMIR Cardio:
- Rivers JT, Smith C, Smith I, Cameron J. The Impact of a Mobile App on Participation in Cardiac Rehabilitation and Understanding Barriers to Success: Comparative Cohort Study. JMIR Cardio. 2022;6(1):e24174. doi:10.2196/24174
- Clinical study finds that offering digital health platform Cardihab increases participation in cardiac rehabilitation - Digital Health Science News - summary
Evidence Presentations And Resources
Canadian Cardiovascular Congress
Presented at the Canadian Cardiovascular Congress 2022
Rivers JT, Smith C, Smith I, Cameron J.
AFFILIATIONS: 1. Queensland Cardiovascular Group, Brisbane, Australia; 2. St. Andrews War Memorial Hospital, Brisbane, Australia; 3. St. Vincent's Private Hospital Northside, Brisbane, Australia
Cardiac Society of Australia and New Zealand
The Cardiac Society of Australia and New Zealand is a professional body dedicated to advancing cardiovascular health. Presented at the CSANZ 2023 ASM.
Rivers JT, Souris H, Jennings G, Kwong C, Smith I.
Key findings include:
- The mode of CR engagement impacts completion rates, with Cardihab achieving a 5-fold increase in odds over other forms.
- Patient groups with low uptake of CR (older age, remote location and financial disadvantage) should be specifically targeted with digital programs to improve treatment equity.
- There is a need to standardise CR programs and define successful completion. The metrics that underpin completion of a CR program should be outcome focused to improve patient outcomes.
Systematic Review
Digital Health Programs to Reduce Readmissions in Coronary Artery Disease: A Systematic Review and Meta-Analysis
A comprehensive systematic review and meta-analysis examining the impact of digital health programs on reducing readmissions in coronary artery disease.
The study found that compared to Disease Management Programs without mHealth, mHealth-enabled programs significantly reduced:
• All-cause hospitalizations (RR: 0.68; 95% CI: 0.50-0.91)
• Cardiac-related hospitalizations (RR: 0.55; 95% CI: 0.44-0.68)
• Emergency department visits (RR: 0.37; 95% CI: 0.26-0.54)
Braver J, et al. JACC Adv. 2023;2(8):100591.
Published in JACC Advances:
Research And Partners
Our Research
Cardihab is proud to collaborate with leading research partners on clinical trials and projects that help define future healthcare needs, and improve patient outcomes.
If you would be interested in learning more about a clinical trial, please get in touch.
The Baker Heart And Diabetes Institute
The Baker Heart and Diabetes Institute is an independent, internationally renowned medical research facility.
Cardihab and the Baker Heart and Diabetes Institute currently have a five-year agreement involving clinical trials and cohort studies that review the effectiveness of digital approaches to cardiovascular disease management, rehabilitation, prevention and treatment.
Australian Centre For Heart Health
The Australian Centre for Heart Health is an organisation dedicated to supporting people who have had a cardiac event in their psychological, social and behavioural recovery.
The Centre's evidence-based resources are available to patients via the Cardihab education libraries.
Heart Support Australia
Heart Support Australia offers a comprehensive peer support group program designed for patients to participate in following their cardiac rehabilitation program, to help build connections and ensure ongoing care in their communities.